Guangdong Jiaying Pharmaceutical Co Ltd (002198) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Guangdong Jiaying Pharmaceutical Co Ltd (002198) has a cash flow conversion efficiency ratio of -0.065x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-45.73 Million ≈ $-6.69 Million USD) by net assets (CN¥709.01 Million ≈ $103.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Guangdong Jiaying Pharmaceutical Co Ltd (002198) liquidity interval to measure how many days the company can operate on defensive assets alone.
Guangdong Jiaying Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Guangdong Jiaying Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Guangdong Jiaying Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangdong Jiaying Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dolly Varden Silver Corporation
V:DV
|
-0.042x |
|
MFS Charter Income Trust
NYSE:MCR
|
0.017x |
|
Samsung C and T 1P Pref
KO:02826K
|
0.018x |
|
MTM Critical Metals Ltd
AU:MTM
|
-0.097x |
|
Rithm Acquisition Corp.
NYSE:RAC
|
-0.001x |
|
Honest Company Inc
NASDAQ:HNST
|
-0.003x |
|
Fossil Group Inc
NASDAQ:FOSL
|
-0.262x |
|
Launch One Acquisition Corp. Unit
NASDAQ:LPAAU
|
0.000x |
Annual Cash Flow Conversion Efficiency for Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)
The table below shows the annual cash flow conversion efficiency of Guangdong Jiaying Pharmaceutical Co Ltd from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Guangdong Jiaying Pharmaceutical Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥717.93 Million ≈ $105.06 Million |
CN¥9.00 Million ≈ $1.32 Million |
0.013x | -84.38% |
| 2024-12-31 | CN¥758.22 Million ≈ $110.95 Million |
CN¥60.85 Million ≈ $8.90 Million |
0.080x | -37.81% |
| 2023-12-31 | CN¥762.98 Million ≈ $111.65 Million |
CN¥98.45 Million ≈ $14.41 Million |
0.129x | +246.14% |
| 2022-12-31 | CN¥728.42 Million ≈ $106.59 Million |
CN¥27.15 Million ≈ $3.97 Million |
0.037x | -50.74% |
| 2021-12-31 | CN¥684.48 Million ≈ $100.16 Million |
CN¥51.80 Million ≈ $7.58 Million |
0.076x | -46.64% |
| 2020-12-31 | CN¥683.01 Million ≈ $99.95 Million |
CN¥96.87 Million ≈ $14.18 Million |
0.142x | +625.55% |
| 2019-12-31 | CN¥663.17 Million ≈ $97.04 Million |
CN¥12.96 Million ≈ $1.90 Million |
0.020x | -75.28% |
| 2018-12-31 | CN¥785.35 Million ≈ $114.92 Million |
CN¥62.10 Million ≈ $9.09 Million |
0.079x | +93.56% |
| 2017-12-31 | CN¥749.81 Million ≈ $109.72 Million |
CN¥30.63 Million ≈ $4.48 Million |
0.041x | -24.27% |
| 2016-12-31 | CN¥984.87 Million ≈ $144.12 Million |
CN¥53.13 Million ≈ $7.77 Million |
0.054x | +18.52% |
| 2015-12-31 | CN¥929.70 Million ≈ $136.04 Million |
CN¥42.31 Million ≈ $6.19 Million |
0.046x | -61.99% |
| 2014-12-31 | CN¥863.35 Million ≈ $126.33 Million |
CN¥103.36 Million ≈ $15.13 Million |
0.120x | +398.08% |
| 2013-12-31 | CN¥809.66 Million ≈ $118.48 Million |
CN¥19.46 Million ≈ $2.85 Million |
0.024x | +26.80% |
| 2012-12-31 | CN¥278.08 Million ≈ $40.69 Million |
CN¥5.27 Million ≈ $771.40K |
0.019x | +555.86% |
| 2011-12-31 | CN¥270.51 Million ≈ $39.58 Million |
CN¥781.89K ≈ $114.42K |
0.003x | -96.21% |
| 2010-12-31 | CN¥258.47 Million ≈ $37.82 Million |
CN¥19.70 Million ≈ $2.88 Million |
0.076x | -34.25% |
| 2009-12-31 | CN¥241.42 Million ≈ $35.33 Million |
CN¥27.98 Million ≈ $4.09 Million |
0.116x | +144.87% |
| 2008-12-31 | CN¥226.35 Million ≈ $33.12 Million |
CN¥10.71 Million ≈ $1.57 Million |
0.047x | -45.15% |
| 2007-12-31 | CN¥212.62 Million ≈ $31.11 Million |
CN¥18.35 Million ≈ $2.68 Million |
0.086x | -72.96% |
| 2006-12-31 | CN¥82.63 Million ≈ $12.09 Million |
CN¥26.37 Million ≈ $3.86 Million |
0.319x | +16.54% |
| 2005-12-31 | CN¥64.39 Million ≈ $9.42 Million |
CN¥17.63 Million ≈ $2.58 Million |
0.274x | +52.64% |
| 2004-12-31 | CN¥48.97 Million ≈ $7.17 Million |
CN¥8.78 Million ≈ $1.29 Million |
0.179x | -- |
About Guangdong Jiaying Pharmaceutical Co Ltd
Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat, cold, orthopedics, rheumatism, gynecology, heat-clearing, tonic, and gastrointestinal diseases. It also provides Shuangliao Houfeng powder, Chongganling tablets, Jiegu Qili tablet… Read more